Stewart J M, Gewitz M H, Clark B J, Seligman K P, Romano A, Zeballos G A, Chang A, Murdison K, Woolf P K, Norwood W I
Department of Pediatrics, New York Medical College, Westchester Medical Center, Valhalla 10595.
J Thorac Cardiovasc Surg. 1991 Dec;102(6):821-9.
The Fontan procedure results in right atrial distention and is complicated by fluid retention. Since systemic fluid balance may be hormonally mediated in part and related to right atrium size, we measured plasma atrial natriuretic factor and plasma arginine vasopressin levels in 19 patients undergoing the Fontan procedure and in 12 control patients undergoing other types of heart operations. Preoperative plasma atrial natriuretic factor levels were higher in patients undergoing the Fontan procedure than in control patients (95 +/- 16 pg/ml preoperatively versus 50 +/- 8 pg/ml; p less than 0.05) and increased in patients undergoing the Fontan procedure to 330 +/- 48 pg/ml by postoperative day 2 (p less than 0.05) but not in control patients. Increased plasma atrial natriuretic factor levels could enhance capillary transudation, but elevated plasma atrial natriuretic factor levels should also enhance diuresis and prevent fluid retention. Vasopressin levels, however, were also increased in patients undergoing the Fontan procedure (from 9 +/- 2 pg/ml preoperatively to 144 +/- 37 pg/ml at end of operation) and were higher and remained elevated longer than in control patients undergoing heart operations (37 +/- 7, 20 +/- 4, 16 +/- 6 pg/ml on postoperative days 1, 2, and 3 to 10 for the Fontan group compared with 15 +/- 4, 4 +/- 1, 4 +/- 2 pg/ml for control patients). Vasopressin levels were highest in the Fontan group with the most severe fluid retention and effusions (for example, 51 +/- 10 pg/ml versus 23 +/- 4 pg/ml, on postoperative day 1). Increased vasopressin and atrial natriuretic factor could act synergistically to result in the development of effusions after the Fontan procedure when atrial natriuretic factor-induced capillary transudation is combined with vasopressin-induced antidiuresis.
Fontan手术会导致右心房扩张,并伴有液体潴留的并发症。由于全身液体平衡可能部分受激素调节且与右心房大小有关,我们对19例接受Fontan手术的患者和12例接受其他类型心脏手术的对照患者进行了血浆心房利钠因子和血浆精氨酸加压素水平的测定。接受Fontan手术的患者术前血浆心房利钠因子水平高于对照患者(术前为95±16 pg/ml,而对照患者为50±8 pg/ml;p<0.05),接受Fontan手术的患者术后第2天该水平升高至330±48 pg/ml(p<0.05),而对照患者则未升高。血浆心房利钠因子水平升高可增强毛细血管滤过,但升高的血浆心房利钠因子水平也应增强利尿并防止液体潴留。然而,接受Fontan手术的患者加压素水平也升高(从术前的9±2 pg/ml升至手术结束时的144±37 pg/ml),且比接受心脏手术的对照患者更高且升高持续时间更长(Fontan组术后第1、2和3至10天分别为37±7、20±4、16±6 pg/ml,而对照患者分别为15±4、4±1、4±2 pg/ml)。Fontan组中液体潴留和积液最严重的患者加压素水平最高(例如,术后第1天为51±10 pg/ml,而对照患者为23±4 pg/ml)。当心房利钠因子诱导的毛细血管滤过与加压素诱导的抗利尿作用相结合时,加压素和心房利钠因子升高可能协同作用导致Fontan手术后积液的发生。